Back to List View Graph View

Glutathione Peroxidase 4 (GPX4)

glutathione peroxidase 4 (Gpx4) is a selenoprotein enzyme that plays a central role in cellular antioxidant defense by reducing lipid hydroperoxides to non-toxic lipid alcohols.

Where the papers sit

13 papers from the last 6 months study Glutathione Peroxidase 4 (GPX4) directly · updated from PubMed 11 Nov 2026

Study type 0 clinical trials · 10 preclinical · 3 unclassified

Themes 3 themes

  • Ferroptosis-Based Cancer Therapy

    Cancer treatment is moving toward deliberately inducing ferroptosis by disabling GPX4-dependent redox defenses. Curcumin, pyrazolone compounds, and ferrous-supply-regenerating RNAi nanoparticles are tested against thyroid, breast, and other tumors. HSPA5 stabilization and mitochondrial ribosomal protein S30 instead show how tumors preserve GPX4 to evade lipid peroxidation. Ferroptosis markers, DNA repair, and transporter proteins are also being evaluated as predictors of platinum sensitivity and prognosis.

    6 papers · 46.2%

  • Ferroptosis in Cancer and Injury

    GPX4-centered redox control links ferroptosis to chemotherapy resistance, cardiomyocyte toxicity, neuroblastoma treatment, and diabetic kidney injury. MYC/FTH1, ATF4, USF1, and SIRT3 pathways repeatedly alter GPX4 activity or expression. Some studies aim to trigger ferroptosis in tumors, whereas others preserve GPX4 to protect normal tissue. The shared direction is pathway-specific control of ferroptosis rather than a single therapeutic strategy.

    4 papers · 30.8%

  • Tissue Protection from Ferroptosis

    Ferroptosis inhibition is being developed to limit damage in sepsis, acute glaucoma, and cisplatin-induced kidney injury. Irinotecan repurposing targets FAR1-dependent macrophage ferroptosis, while engineered exosomes and polydopamine nanoparticles aim to reduce lipid peroxidation and preserve tissue survival. ACSL4 and related lipid-metabolism pathways recur as therapeutic control points. The work favors targeted delivery and tissue protection over systemic ferroptosis activation.

    3 papers · 23.1%

Papers

The 13 papers from the last 6 months that study Glutathione Peroxidase 4 (GPX4) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Ferroptosis-Based Cancer Therapy (6)
  1. HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular signalling · 22 Aug 2026 PMID 42632529
  2. Ferroptosis, DNA damage repair, and transporter proteins: associated with platinum sensitivity and prognosis in epithelial ovarian cancer. Molecular biology reports · 13 Aug 2026 PMID 42593694
  3. Ferroptosis induction by curcumin through regulating the expression of glutathione peroxidase 4 in papillary thyroid carcinoma. Journal of molecular histology · 4 Aug 2026 PMID 42550316
  4. Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination. International journal of biological macromolecules · 1 Aug 2026 PMID 42542152
  5. A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) · 30 Jul 2026 PMID 42528415
  6. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
Ferroptosis in Cancer and Injury (4)
  1. Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4. Cancer chemotherapy and pharmacology · 6 Aug 2026 PMID 42560559
  2. Lapatinib Induces Ferroptosis in Cardiomyocytes by Regulating ATF4/GPX4. Cardiovascular toxicology · 24 Jul 2026 PMID 42496814
  3. miR-145-5p Targets KLF4 to Regulate the SIRT3/GPX4 Axis, Mediating Ferroptosis and Exacerbating Tubular Epithelial Cell Injury in Diabetic Nephropathy. Nephrology (Carlton, Vic.) · 24 Jul 2026 PMID 42494277
  4. Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1/GPX4 axis. Bioorganic chemistry · 20 Jun 2026 PMID 42322906
Tissue Protection from Ferroptosis (3)
  1. PEBP1 Regulates Ferroptosis in Acute Glaucoma: Targeted Therapy Using Engineered Exosomes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 3 Sept 2026 PMID 42687852
  2. Targeting FAR1 to inhibit intestinal macrophage ferroptosis: repurposing irinotecan as a novel sepsis therapy. Apoptosis : an international journal on programmed cell death · 19 Aug 2026 PMID 42616198
  3. Multifunctional Polydopamine Nanoparticles to Alleviate Oxidative Stress and Inhibit Ferroptosis for Cisplatin-Induced Acute Kidney Injury Therapy. Molecular pharmaceutics · 11 Jul 2026 PMID 42435348

By study type

Preclinical: animal, cell and lab studies (10)
  1. PEBP1 Regulates Ferroptosis in Acute Glaucoma: Targeted Therapy Using Engineered Exosomes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 3 Sept 2026 PMID 42687852
  2. Targeting FAR1 to inhibit intestinal macrophage ferroptosis: repurposing irinotecan as a novel sepsis therapy. Apoptosis : an international journal on programmed cell death · 19 Aug 2026 PMID 42616198
  3. Ferroptosis, DNA damage repair, and transporter proteins: associated with platinum sensitivity and prognosis in epithelial ovarian cancer. Molecular biology reports · 13 Aug 2026 PMID 42593694
  4. Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4. Cancer chemotherapy and pharmacology · 6 Aug 2026 PMID 42560559
  5. Ferroptosis induction by curcumin through regulating the expression of glutathione peroxidase 4 in papillary thyroid carcinoma. Journal of molecular histology · 4 Aug 2026 PMID 42550316
  6. Lapatinib Induces Ferroptosis in Cardiomyocytes by Regulating ATF4/GPX4. Cardiovascular toxicology · 24 Jul 2026 PMID 42496814
  7. miR-145-5p Targets KLF4 to Regulate the SIRT3/GPX4 Axis, Mediating Ferroptosis and Exacerbating Tubular Epithelial Cell Injury in Diabetic Nephropathy. Nephrology (Carlton, Vic.) · 24 Jul 2026 PMID 42494277
  8. Multifunctional Polydopamine Nanoparticles to Alleviate Oxidative Stress and Inhibit Ferroptosis for Cisplatin-Induced Acute Kidney Injury Therapy. Molecular pharmaceutics · 11 Jul 2026 PMID 42435348
  9. Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1/GPX4 axis. Bioorganic chemistry · 20 Jun 2026 PMID 42322906
  10. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
Unclassified: not yet indexed with MeSH (3)
  1. HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular signalling · 22 Aug 2026 PMID 42632529
  2. Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination. International journal of biological macromolecules · 1 Aug 2026 PMID 42542152
  3. A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) · 30 Jul 2026 PMID 42528415